Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C21H36N7O16P3S |
| Molecular Weight | 767.534 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 5 / 5 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)(COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(O)(O)=O)N2C=NC3=C2N=CN=C3N)[C@@H](O)C(=O)NCCC(=O)NCCS
InChI
InChIKey=RGJOEKWQDUBAIZ-IBOSZNHHSA-N
InChI=1S/C21H36N7O16P3S/c1-21(2,16(31)19(32)24-4-3-12(29)23-5-6-48)8-41-47(38,39)44-46(36,37)40-7-11-15(43-45(33,34)35)14(30)20(42-11)28-10-27-13-17(22)25-9-26-18(13)28/h9-11,14-16,20,30-31,48H,3-8H2,1-2H3,(H,23,29)(H,24,32)(H,36,37)(H,38,39)(H2,22,25,26)(H2,33,34,35)/t11-,14-,15-,16+,20-/m1/s1
| Molecular Formula | C21H36N7O16P3S |
| Molecular Weight | 767.534 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 5 / 5 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
DescriptionSources: https://web.archive.org/web/20170627111600/http://coenzyme-a.com:80/coenzymea_article.htmlCurator's Comment: description was created based on several sources, including:
http://orthomolecular.org/library/jom/1997/articles/1997-v12n02-p099.shtml
http://www.tandurust.com/health-faq-8/coenzyme-a-supplement-benefits.html
http://www.wikidoc.org/index.php/Coenzyme_A
Sources: https://web.archive.org/web/20170627111600/http://coenzyme-a.com:80/coenzymea_article.html
Curator's Comment: description was created based on several sources, including:
http://orthomolecular.org/library/jom/1997/articles/1997-v12n02-p099.shtml
http://www.tandurust.com/health-faq-8/coenzyme-a-supplement-benefits.html
http://www.wikidoc.org/index.php/Coenzyme_A
Coenzyme A (CoA) is a ubiquitous essential cofactor that plays a central role in the metabolism of carboxylic acids, including short- and long-chain fatty acids, as well as carbohydrate and protein. In the metabolic pathway of lipid, CoA participates in fatty acid β-oxidation, promoting triglyceride (TG) catabolism. Coenzyme A functions as an acyl group carrier and assists in transferring fatty acids from the cytoplasm to mitochondria. All genomes sequenced to date encode enzymes that use coenzyme A as a substrate, and around 4% of cellular enzymes use it (or a thioester, such as acetyl-CoA) as a substrate. Coenzyme A is the most active metabolic enzyme in the human body. It is used as a supplement for the hypothetical treatment of acne.
Originator
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: 84532.0 Gene Symbol: ACSS1 Sources: http://www.ncbi.nlm.nih.gov/pubmed/15316652 |
|||
Target ID: 55902.0 Gene Symbol: ACSS2 Sources: http://www.ncbi.nlm.nih.gov/pubmed/15316652 |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Primary | Unknown Approved UseUnknown |
|||
| Palliative | PERFECT SLEEP Approved UseGRAS. For temporary reduction of the symptoms of insomnia |
|||
| Preventing | ANTI AGING AND WRINKLES FOR WOMEN Approved UseGRAS. Used as a natural aid for premature aging |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Crystallographic and kinetic studies of human mitochondrial acetoacetyl-CoA thiolase: the importance of potassium and chloride ions for its structure and function. | 2007-04-10 |
|
| The identification of a succinyl-CoA thioesterase suggests a novel pathway for succinate production in peroxisomes. | 2005-11-18 |
|
| Discovery and directed evolution of a glyphosate tolerance gene. | 2004-05-21 |
|
| A novel Arabidopsis acetyltransferase interacts with the geminivirus movement protein NSP. | 2003-07 |
|
| ERG10 from Saccharomyces cerevisiae encodes acetoacetyl-CoA thiolase. | 1994-12-16 |
|
| 2-Aminobenzoyl-CoA monooxygenase/reductase, a novel type of flavoenzyme. Identification of the reaction products. | 1990-07-31 |
|
| Microbial metabolism of short-chain unsaturated hydrocarbons. | 1989-09 |
|
| The structure of coenzyme A. | 1955 |
|
| Studies concerning the structure of coenzyme A. | 1953-03 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://clinicaltrials.gov/ct2/show/NCT01811082
400 mg per day
Route of Administration:
Oral
In Vitro Use Guide
Sources: http://www.ncbi.nlm.nih.gov/pubmed/5228587
Plasmodium lophurae maintained extracellularly in a dilute duck erythrocyte extract requires an external source of coenzyme A (40 ug/ml).
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 17:58:27 GMT 2025
by
admin
on
Mon Mar 31 17:58:27 GMT 2025
|
| Record UNII |
SAA04E81UX
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
85-61-0
Created by
admin on Mon Mar 31 17:58:27 GMT 2025 , Edited by admin on Mon Mar 31 17:58:27 GMT 2025
|
PRIMARY | |||
|
COENZYME A
Created by
admin on Mon Mar 31 17:58:27 GMT 2025 , Edited by admin on Mon Mar 31 17:58:27 GMT 2025
|
PRIMARY | |||
|
100000079792
Created by
admin on Mon Mar 31 17:58:27 GMT 2025 , Edited by admin on Mon Mar 31 17:58:27 GMT 2025
|
PRIMARY | |||
|
15346
Created by
admin on Mon Mar 31 17:58:27 GMT 2025 , Edited by admin on Mon Mar 31 17:58:27 GMT 2025
|
PRIMARY | |||
|
1314344
Created by
admin on Mon Mar 31 17:58:27 GMT 2025 , Edited by admin on Mon Mar 31 17:58:27 GMT 2025
|
PRIMARY | RxNorm | ||
|
201-619-0
Created by
admin on Mon Mar 31 17:58:27 GMT 2025 , Edited by admin on Mon Mar 31 17:58:27 GMT 2025
|
PRIMARY | |||
|
87642
Created by
admin on Mon Mar 31 17:58:27 GMT 2025 , Edited by admin on Mon Mar 31 17:58:27 GMT 2025
|
PRIMARY | |||
|
SAA04E81UX
Created by
admin on Mon Mar 31 17:58:27 GMT 2025 , Edited by admin on Mon Mar 31 17:58:27 GMT 2025
|
PRIMARY | |||
|
DB01992
Created by
admin on Mon Mar 31 17:58:27 GMT 2025 , Edited by admin on Mon Mar 31 17:58:27 GMT 2025
|
PRIMARY | |||
|
SUB13431MIG
Created by
admin on Mon Mar 31 17:58:27 GMT 2025 , Edited by admin on Mon Mar 31 17:58:27 GMT 2025
|
PRIMARY | |||
|
DTXSID9048302
Created by
admin on Mon Mar 31 17:58:27 GMT 2025 , Edited by admin on Mon Mar 31 17:58:27 GMT 2025
|
PRIMARY | |||
|
m3720
Created by
admin on Mon Mar 31 17:58:27 GMT 2025 , Edited by admin on Mon Mar 31 17:58:27 GMT 2025
|
PRIMARY | Merck Index | ||
|
SAA04E81UX
Created by
admin on Mon Mar 31 17:58:27 GMT 2025 , Edited by admin on Mon Mar 31 17:58:27 GMT 2025
|
PRIMARY | |||
|
C384
Created by
admin on Mon Mar 31 17:58:27 GMT 2025 , Edited by admin on Mon Mar 31 17:58:27 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|